(Q49073651)

18 February 2018

title

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. (English)

1 reference

18 February 2018

0 references

0 references

2

1 reference

18 February 2018

Alberto Ascherio

10

object named as

A Ascherio

1 reference

18 February 2018

Kassandra L Munger

8

object named as

Kl Munger

1 reference

18 February 2018

Éilis J. O'Reilly

7

object named as

Ej O'Reilly

1 reference

18 February 2018

author name string

F Di Pauli

1

1 reference

18 February 2018

R Ehling

3

1 reference

18 February 2018

F Schautzer

4

1 reference

18 February 2018

C Gneiss

5

1 reference

18 February 2018

A Lutterotti

6

1 reference

18 February 2018

F Deisenhammer

9

1 reference

18 February 2018

T Berger

11

1 reference

18 February 2018

publication date

16 July 2008

1 reference

18 February 2018

Multiple Sclerosis Journal

published in

1 reference

18 February 2018

volume

14

1 reference

18 February 2018

issue

8

1 reference

18 February 2018

page(s)

1026-1030

1 reference

18 February 2018

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Multiple sclerosis: the environment and causation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Cigarette smoking and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Cigarette smoking and the progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Chemical composition of tobacco and tobacco smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Cyanide in human disease: A review of clinical and laboratory evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Smoking and immunity: an additional player in the mosaic of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

Immunomodulatory effects of cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093679

21 January 2018

Identifiers

DOI

10.1177/1352458508093679

1 reference

18 February 2018

1 reference

18 February 2018